2020
DOI: 10.1016/j.bioelechem.2020.107589
|View full text |Cite
|
Sign up to set email alerts
|

Polyethylene glycol-mediated blocking and monolayer morphology of an electrochemical aptasensor for malaria biomarker detection in human serum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 34 publications
(25 citation statements)
references
References 64 publications
1
20
0
Order By: Relevance
“…5 A). Furthermore, thiol terminated PEG molecules were used as anti-fouling backfill to suppress unspecific binding [ 78 ]. The binding of the target to the receptor layer induced conformational changes within the aptamer film.…”
Section: Resultsmentioning
confidence: 99%
“…5 A). Furthermore, thiol terminated PEG molecules were used as anti-fouling backfill to suppress unspecific binding [ 78 ]. The binding of the target to the receptor layer induced conformational changes within the aptamer film.…”
Section: Resultsmentioning
confidence: 99%
“…We and others observed that SAMs with molecular structural variations in charges proved to greatly impact their wettability and antifouling properties. 27,30,31 We anticipate that such ability of SAMs to modulate these surface properties would, in retrospect, provide a means to tune the performance of E-AB sensors, such as baseline stability, sensitivity, specificity, etc. As our proof-of-concept study, we incorporated here a DOX-detecting aptamer into an E-AB sensor platform and fabricated a series of sensors from six SAMs.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Nevertheless, still some challenges in the LOD and the requirement of complex microfluidic systems strongly limit their practicality. Very low LODs are achieved by electrochemical biosensors, but they only work with serum [25,26] or serial dilutions are needed if a quantitative measurement is required [27]. Fluorescence-based biosensors show a great potential for point-of-care applications since the sensitivity can be drastically increased by using plasmon nanostructures as a fluorescence enhancer and the sample pretreatment can be avoided [12].…”
Section: Introductionmentioning
confidence: 99%